ZIMBERELIMAB
22-141
Phase 2 small_molecule on_hold
Quick answer
ZIMBERELIMAB for Pancreatic Cancer is a Phase 2 program (small_molecule) at Arcus Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcus Biosciences
- Indication
- Pancreatic Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- on_hold